Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation
- Bioorg Med Chem. 2002 Sep;10(9):2987-92. doi: 10.1016/s0968-0896(02)00129-3.
Affiliations
- 1. Department of Bioscience and Biotechnology, Institute of Bioscience, Sejong University, 98 Kunja-dong, Kwangjin-gu, 143-747, Seoul, South Korea
PMID: 12110321
DOI: 10.1016/s0968-0896(02)00129-3
Abstract
Curcumin and some of its derivatives were known as in vivo inhibitors of angiogenesis. In present study, a novel curcumin derivative, named hydrazinocurcumin (HC) was synthesized and examined for its biological activities. HC potently inhibited the proliferation of bovine aortic endothelial cells (BAECs) at a nanomolar concentration (IC(50)=520 nM) without cytotoxicity. In vivo and in vitro angiogenesis experiments showed HC as a new candidate for anti-angiogenic agent.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-